Stock EXEL EXELIXIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Exelixis, Inc.

Equities

EXEL

US30161Q1040

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-15 EDT 		5-day change 1st Jan Change
21.12 USD +0.62% Intraday chart for Exelixis, Inc. -2.18% -11.96%
05-14 Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target MT
05-10 Exelixis Files Patent Complaint Against Cipla's Cancer Treatment DJ
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
EXELIXIS, INC. Stock Exelixis, Inc.
 6.11B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 22.24B -
ARGENX SE Stock argenx SE
 21.25B -
GENMAB A/S Stock Genmab A/S
 18.97B
  1. Stock Market
  2. Equities
  3. EXEL Stock
  4. Charts Exelixis, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW